BlackBoxRX
 
We highly recommend enabling Javascript while using the BlackBoxRX site.

Fenfluramine

Valvular Heart Disease and Pulmonary Arterial Hypertension

  • There is an association between serotonergic drugs with 5-HT2B receptor agonist activity, including fenfluramine (the active ingredient in FINTEPLA), and valvular heart disease and pulmonary arterial hypertension.¬†
  • Echocardiogram assessments are required before, during, and after treatment with FINTEPLA.¬†
  • FINTEPLA is available only through a restricted program called the FINTEPLA REMS

Approved Risk Evaluation and Mitigation Strategies (REMS)

FINTEPLA (fenfluramine) Oral Solution)

Patient Counseling Information

Medication Guides

Patient Medication Guide - GINTEPLA

Package Inserts

Fenfluramine 

Updated July 2020